Pathology and Laboratory Medicine

This track explores the applications of next-generation sequencing in clinical diagnostics, genetic testing, cancer profiling, rare disease diagnosis, variant interpretation, and personalized healthcare.

This session covers whole-slide imaging, digital pathology platforms, computational pathology, image analysis, telepathology, quantitative pathology, and technology-driven approaches for improving diagnostic accuracy and workflow efficiency.

This session examines the growing role of artificial intelligence, machine learning, deep learning, and computer vision in pathology. Topics include AI-assisted image analysis, automated disease classification, predictive analytics, and intelligent diagnostic decision-support systems.

This track focuses on integrating pathological, molecular, genomic, and clinical information to support individualized diagnosis and treatment. Discussions will include predictive biomarkers, patient stratification, companion diagnostics, and personalized healthcare.

This session explores advances in cancer diagnosis and molecular characterization, including tumor pathology, molecular tumor classification, cancer biomarkers, immunohistochemistry, genomic profiling, liquid biopsy, immuno-oncology, and targeted therapies.

This session focuses on biomarker discovery, validation, diagnostic signatures, predictive and prognostic biomarkers, and the translation of laboratory research into clinically useful diagnostic and therapeutic applications.

This track explores circulating tumor DNA, cell-free DNA, circulating tumor cells, extracellular vesicles, and other minimally invasive biomarkers for early disease detection, cancer monitoring, treatment response assessment, and disease surveillance.

This session focuses on modern developments in tissue diagnosis, histopathological examination, immunohistochemistry, tissue processing, tumor classification, diagnostic reporting, and innovative approaches to surgical pathology.

This track covers advances in cytological diagnosis, fine-needle aspiration, liquid-based cytology, molecular cytology, digital cytology, and emerging technologies for early and accurate disease detection.

This session explores modern approaches to diagnosing leukemia, lymphoma, myeloma, and other hematological disorders using morphology, flow cytometry, cytogenetics, molecular diagnostics, and genomic analysis.

This track focuses on clinical chemistry, biochemical testing, laboratory biomarkers, automated analyzers, diagnostic assays, point-of-care testing, and emerging laboratory approaches for disease diagnosis and patient monitoring.

This session examines molecular pathogen detection, antimicrobial susceptibility testing, antimicrobial resistance, emerging infections, infectious disease biomarkers, rapid diagnostics, and advanced microbiological testing methods.

This session explores automated laboratory systems, robotics, laboratory information systems, data integration, artificial intelligence, high-throughput testing, smart workflows, and digital technologies designed to improve laboratory efficiency and quality.

This forward-looking session will explore technologies expected to shape the future of diagnostic medicine, including advanced molecular testing, AI-driven diagnostics, multi-omics, precision pathology, digital transformation, advanced biomarkers, and next-generation laboratory technologies.